The identification of tumor-associated MHC peptides, including those with PTMs, are of high interest as possible biomarkers or immunotherapeutic targets since cancer and other chronic diseases can evade detection by the immune system, in part, by dysregulation of cellular signaling. The gene discussed is HLA-C; the disease is cancer.